APA (7th ed.) Citation

I, T., B, A., G, S., I, B., L, E., JS, J., . . . Laack, E. (2010). Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer. Cancer (0008543X), 116(17), 4114. https://doi.org/10.1002/cncr.25196

Chicago Style (17th ed.) Citation

I, Thöm, et al. "Elevated Pretreatment Serum Concentration of YKL-40-An Independent Prognostic Biomarker for Poor Survival in Patients with Metastatic Nonsmall Cell Lung Cancer." Cancer (0008543X) 116, no. 17 (2010): 4114. https://doi.org/10.1002/cncr.25196.

MLA (9th ed.) Citation

I, Thöm, et al. "Elevated Pretreatment Serum Concentration of YKL-40-An Independent Prognostic Biomarker for Poor Survival in Patients with Metastatic Nonsmall Cell Lung Cancer." Cancer (0008543X), vol. 116, no. 17, 2010, p. 4114, https://doi.org/10.1002/cncr.25196.